Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary V Relling

Showing results (161-170 of 257) with videos related to

Pageof 26
Sort By:
Blood|June 30, 2017
Novel variants in <i>NUDT15</i> and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestryTakaya Moriyama, Yung-Li Yang, Rina Nishii, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2023
Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALLShawn H R Lee, Emily Ashcraft, Wenjian Yang, et al.
Leukemia|August 5, 2023
Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemiaKeito Hoshitsuki, Yinmei Zhou, April M Miller, et al.
Blood|January 23, 2014
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemiaWing H Tong, Rob Pieters, Gertjan J L Kaspers, et al.
Pharmacogenetics and Genomics|February 15, 2013
Nomenclature for alleles of the thiopurine methyltransferase geneMalin L Appell, Jonathan Berg, John Duley, et al.
Clinical Pharmacology and Therapeutics|November 18, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 UpdateMary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, et al.
The Lancet. Oncology|March 25, 2015
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective studyChing-Hon Pui, Deqing Pei, Elaine Coustan-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoidsSue C Kaste, Deqing Pei, Cheng Cheng, et al.
Nature Medicine|September 28, 2011
Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cellsBarthelemy Diouf, Qing Cheng, Natalia F Krynetskaia, et al.
JAMA Oncology|July 17, 2015
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group StudySmita Bhatia, Wendy Landier, Lindsey Hageman, et al.
Pageof 26

Showing results (161-170 of 257) with videos related to

Sort By:
Pageof 26
Blood|June 30, 2017
Novel variants in <i>NUDT15</i> and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestryTakaya Moriyama, Yung-Li Yang, Rina Nishii, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2023
Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALLShawn H R Lee, Emily Ashcraft, Wenjian Yang, et al.
Leukemia|August 5, 2023
Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemiaKeito Hoshitsuki, Yinmei Zhou, April M Miller, et al.
Blood|January 23, 2014
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemiaWing H Tong, Rob Pieters, Gertjan J L Kaspers, et al.
Pharmacogenetics and Genomics|February 15, 2013
Nomenclature for alleles of the thiopurine methyltransferase geneMalin L Appell, Jonathan Berg, John Duley, et al.
Clinical Pharmacology and Therapeutics|November 18, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 UpdateMary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, et al.
The Lancet. Oncology|March 25, 2015
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective studyChing-Hon Pui, Deqing Pei, Elaine Coustan-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoidsSue C Kaste, Deqing Pei, Cheng Cheng, et al.
Nature Medicine|September 28, 2011
Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cellsBarthelemy Diouf, Qing Cheng, Natalia F Krynetskaia, et al.
JAMA Oncology|July 17, 2015
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group StudySmita Bhatia, Wendy Landier, Lindsey Hageman, et al.
Pageof 26